Related Experiment Video
Updated: Aug 4, 2026
Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
[Combined helium-neon laser therapy in patients with ischemic heart disease]
Insights
Combined helium-neon-laser (HNL) therapy, both intravenous and topical, shows high efficacy in elderly patients with refractory angina. This advanced HNL therapy offers greater clinical benefits than topical exposure alone.
Area of Science:
- Cardiovascular Medicine
- Medical Laser Applications
- Biophysics
Context:
- Coronary heart disease (CHD) management
- Refractory angina pectoris in elderly patients (Functional Classes III-IV)
- Limitations of conventional antianginal agents
Purpose:
- To describe a novel combined helium-neon-laser (HNL) therapy (intravenous and topical) for CHD.
- To evaluate the efficacy of this HNL therapy in specific patient populations.
- To investigate the underlying mechanisms of HNL therapy at cellular and membraneous levels.
Summary:
- The study presents a combined intravenous and topical helium-neon-laser (HNL) therapy for coronary heart disease.
- High efficacy was observed in patients over 70 with severe angina unresponsive to standard treatments.
- Mechanisms of laser irradiation were explored, revealing combined HNL-therapy's superior clinical efficiency and impact on chemical changes compared to topical application.
Impact:
- Demonstrates a potentially more effective therapeutic option for refractory angina in the elderly.
- Provides insights into the biophysical mechanisms of laser therapy in cardiovascular disease.
- Highlights advantages of combined HNL therapy over single-mode application for improved patient outcomes.
Abstract:
The paper describes the combined helium-neon-laser (HNL) therapy (intravenous and topical) developed by the authors to treat patients with coronary heart disease. A high efficacy of this therapy mode was demonstrated in patients over 70 years of age with Functional Classes III-IV angina refractory to antianginal agents. The mechanisms responsible for therapeutic efficiency of laser irradiation were studied at the membraneous and cellular levels. There is evidence that the combined HNL-therapy had advantages over topical HNL exposure in terms of higher clinical efficiency and patterns of abnormal chemical changes.
